Mwanzo207940 • KRX
add
Samsung Biologics Co Ltd
Bei iliyotangulia
₩ 1,585,000.00
Bei za siku
₩ 1,551,000.00 - ₩ 1,631,000.00
Bei za mwaka
₩ 982,000.00 - ₩ 1,987,000.00
Thamani ya kampuni katika soko
71.94T KRW
Wastani wa hisa zilizouzwa
elfu 50.08
Uwiano wa bei na mapato
41.95
Mgao wa faida
-
Kwenye habari
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (KRW) | Des 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 1.45T | 52.94% |
Matumizi ya uendeshaji wa biashara | — | — |
Mapato halisi | — | — |
Kiwango cha faida halisi | — | — |
Mapato kwa kila hisa | elfu 8.72 | 25.60% |
EBITDA | — | — |
Asilimia ya kodi ya mapato | — | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (KRW) | Des 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 1.46T | 12.13% |
Jumla ya mali | 11.06T | -36.20% |
Jumla ya dhima | 3.61T | -43.88% |
Jumla ya hisa | 7.45T | — |
hisa zilizosalia | 54.52M | — |
Uwiano wa bei na thamani | 11.60 | — |
Faida inayotokana na mali | — | — |
Faida inayotokana mtaji | — | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (KRW) | Des 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | — | — |
Pesa kutokana na shughuli | — | — |
Pesa kutokana na uwekezaji | — | — |
Pesa kutokana na ufadhili | — | — |
Mabadiliko halisi ya pesa taslimu | — | — |
Mtiririko huru wa pesa | — | — |
Kuhusu
Samsung Biologics Co., Ltd. is a global contract development and manufacturing organization headquartered in Songdo, Incheon, South Korea. The biotech division of Samsung Group, its core services range from late discovery to large-scale commercial manufacturing. The company focuses on monoclonal antibodies, bispecific antibodies, antibody-drug conjugates, and mRNA vaccines.
The company has partnered with pharmaceutical companies such as Pfizer, GlaxoSmithKline, Eli Lilly, AstraZeneca and Bristol-Myers Squibb. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
2011
Tovuti
Wafanyakazi
5,195
